These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9720808)

  • 1. The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception.
    Griesbacher T; Amann R; Sametz W; Diethart S; Juan H
    Br J Pharmacol; 1998 Jul; 124(6):1328-34. PubMed ID: 9720808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
    Griesbacher T; Legat FJ
    Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
    Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
    Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
    Majima M; Kawashima N; Hiroshi I; Katori M
    Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
    Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
    Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
    Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
    Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
    Félétou M; Lonchampt M; Robineau P; Jamonneau I; Thurieau C; Fauchère JL; Villa P; Ghezzi P; Prost JF; Canet E
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1078-84. PubMed ID: 7791078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
    Gobeil F; Montagne M; Inamura N; Regoli D
    Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the non-peptide B2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation.
    Griesbacher T; Legat FJ
    Inflamm Res; 2000 Oct; 49(10):535-40. PubMed ID: 11089906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
    Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
    Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
    Griesbacher T; Rainer I
    Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation.
    Asano M; Hatori C; Inamura N; Sawai H; Hirosumi J; Fujiwara T; Nakahara K
    Br J Pharmacol; 1997 Dec; 122(7):1436-40. PubMed ID: 9421292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivo.
    Félétou M; Robineau P; Lonchampt M; Bonnardel E; Thurieau C; Fauchère JL; Widdowson P; Mahieu JP; Serkiz B; Volland JP
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1071-7. PubMed ID: 7791077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
    Legat FJ; Griesbacher T; Lembeck F
    Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
    Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
    Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist.
    Chen HS; Chen J
    Eur J Pain; 2000; 4(4):389-401. PubMed ID: 11124011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.
    Corrêa CR; Kyle DJ; Chakraverty S; Calixto JB
    Br J Pharmacol; 1996 Feb; 117(3):552-558. PubMed ID: 8821548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.